Nonprescription Office In Transition Works To Hire Division Heads
This article was originally published in The Tan Sheet
Executive Summary
Filling the posts of division directors is the current primary focus for Office of Nonprescription Products Director Charles Ganley, MD
You may also be interested in...
ONP Has Actual-Use Trial Panel, Rx-To-OTC Switch MaPP In Mind – Ganley
FDA's Office of Nonprescription Products may examine issues surrounding actual-use trials for OTC drugs at an advisory committee meeting later this year
Actual Use, Label Comprehension Guidances Slated For 2006
Guidances under development in 2006 reflect FDA's interest in improving the quality of Rx-to-OTC switch submissions
FDA Office Of Nonprescription Drugs To Assume Switch Management Duties
FDA's recently-christened Office of Nonprescription Drugs will take over project management responsibilities for Rx-to-OTC switches from the primary review division within the Center for Drug Evaluation & Research, according to the agency